Lotus Pharmaceutical Announces $20 Million Loan to Singapore Subsidiary Lotus International

Overview of the Loan On May 21, 2026, Lotus Pharmaceutical (1795) announced, based on a board resolution, that it will provide a loan to its Singapore subsidiary, Lotus International Pte. Ltd.

### Loan Details - **Borrower**: Lotus International Pte. Ltd. (a wholly-owned subsidiary of Lotus) - **Loan Amount**: 633 million TWD (20 million USD) - **Purpose of Loan**: Working capital for the subsidiary's daily operations - **Interest Method**: Fixed annual interest rate of 4.6% - **Repayment Terms**: One year from the date of the first draw-down - **Collateral**: None

### Impact on Financial Position With this additional loan, the outstanding loan balance to the subsidiary will be 633 million TWD. As of the date of the event, the group's total outstanding loan balance is 76.888 billion TWD, which represents 319.94% of the net assets in the most recent financial report of the public issuing company.

The loan amount was calculated based on the Taiwan Bank exchange rate of May 19, 2026 (1 USD = 31.65 TWD).